The FDA launched a new Digital Health Advisory Committee to help the agency oversee and explore digital health tools.
The committee will explore scientific and technical issues related to the following technologies:
- Artificial intelligence
- Augmented reality
- Virtual reality
- Digital therapeutics
- Wearables
- Remote patient monitoring
- Software
The committee will be fully operational in 2024, according to an Oct. 11 FDA news release. The committee will consist of nine voting members, including the chair.
"Digital health technologies are critical for achieving this transformation in care delivery. As digital health technologies advance, the FDA must capitalize on knowledge from inside and outside of the agency to help ensure we appropriately apply our regulatory authority in a way that protects patient health while continuing to support innovation," Jeff Shuren, MD, director of the FDA's Center for Devices and Radiological Health, said in the news release.